Regulatory watch: Impact of scientific advice from the European Medicines Agency
Nat Rev Drug Discov
.
2015 May;14(5):302-3.
doi: 10.1038/nrd4621.
Epub 2015 Apr 17.
Authors
Matthias P Hofer
1
,
Christina Jakobsson
1
,
Nikolaos Zafiropoulos
1
,
Spiros Vamvakas
1
,
Thorsten Vetter
1
,
Jan Regnstrom
1
,
Robert J Hemmings
2
Affiliations
1
European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, UK.
2
Medicines and Healthcare Products Regulatory Agency, 151 Buckingham Palace Road, Victoria, London SW1W 9SZ, UK.
PMID:
25881970
DOI:
10.1038/nrd4621
No abstract available
MeSH terms
Drug Approval / legislation & jurisprudence*
Drug Design*
Europe
Government Agencies
Humans
Risk Assessment / methods